ALINA KULAKEVICH: Open Payments
NPI 1164107207 · PORT CHARLOTTE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,133 in 43 payments from 16 companies in 2025. Trend: 2023 $1,600 · 2024 $3,211 · 2025 $1,133
Food & beverage: $1,115Education: $17
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 10 | $175 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $147 |
| Insmed, Inc. | 5 | $138 |
| ABIOMED | 1 | $128 |
| Merck Sharp & Dohme LLC | 1 | $125 |
| GlaxoSmithKline, LLC. | 4 | $78 |
| Mallinckrodt Hospital Products Inc. | 2 | $70 |
| Actelion Pharmaceuticals US, Inc. | 2 | $39 |
| Verona Pharma, Inc. | 2 | $36 |
| Paratek Pharmaceuticals, Inc. | 2 | $36 |
Products named: GLASSIA, WINREVAIR, Arikayce, AIRSUPRA, ACTHAR, DUPIXENT, FASENRA, NUCALA.
Industry payments across FL — which companies pay providers there.
